vs
IDT CORP（IDT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
IDT CORP的季度营收约是Orthofix Medical Inc.的1.5倍（$322.8M vs $219.9M），IDT CORP净利率更高（6.9% vs -1.0%，领先7.9%），IDT CORP同比增速更快（4.3% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-16.0M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 4.4%）
IDT集团是一家跨国企业，总部位于美国新泽西州纽瓦克市，主营云通信、统一通信、销售点系统业务，同时为特定客户提供金融外汇服务，旗下拥有面向企业与消费者的多条业务线，知名产品包括Boss Revolution预付费电话卡。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
IDT vs OFIX — 直观对比
营收规模更大
IDT
是对方的1.5倍
$219.9M
营收增速更快
IDT
高出2.3%
2.0%
净利率更高
IDT
高出7.9%
-1.0%
自由现金流更多
OFIX
多$32.8M
$-16.0M
两年增速更快
OFIX
近两年复合增速
4.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $322.8M | $219.9M |
| 净利润 | $22.4M | $-2.2M |
| 毛利率 | 36.6% | 71.1% |
| 营业利润率 | 9.6% | 0.2% |
| 净利率 | 6.9% | -1.0% |
| 营收同比 | 4.3% | 2.0% |
| 净利润同比 | 29.6% | 92.4% |
| 每股收益（稀释后） | $0.89 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDTOFIX
| Q4 25 | $322.8M | $219.9M | ||
| Q3 25 | $316.6M | $205.6M | ||
| Q2 25 | $302.0M | $203.1M | ||
| Q1 25 | $303.3M | $193.6M | ||
| Q4 24 | $309.6M | $215.7M | ||
| Q3 24 | $308.8M | $196.6M | ||
| Q2 24 | $299.6M | $198.6M | ||
| Q1 24 | $296.1M | $188.6M |
净利润IDTOFIX
| Q4 25 | $22.4M | $-2.2M | ||
| Q3 25 | $16.9M | $-22.8M | ||
| Q2 25 | $21.7M | $-14.1M | ||
| Q1 25 | $20.3M | $-53.1M | ||
| Q4 24 | $17.2M | $-29.1M | ||
| Q3 24 | $36.8M | $-27.4M | ||
| Q2 24 | $5.6M | $-33.4M | ||
| Q1 24 | $14.4M | $-36.0M |
毛利率IDTOFIX
| Q4 25 | 36.6% | 71.1% | ||
| Q3 25 | 36.2% | 72.2% | ||
| Q2 25 | 37.1% | 68.7% | ||
| Q1 25 | 37.0% | 62.8% | ||
| Q4 24 | 34.8% | 69.0% | ||
| Q3 24 | 33.1% | 68.7% | ||
| Q2 24 | 32.4% | 67.8% | ||
| Q1 24 | 32.7% | 67.5% |
营业利润率IDTOFIX
| Q4 25 | 9.6% | 0.2% | ||
| Q3 25 | 6.9% | -8.3% | ||
| Q2 25 | 8.8% | -7.9% | ||
| Q1 25 | 9.3% | -25.2% | ||
| Q4 24 | 7.6% | -5.3% | ||
| Q3 24 | 6.5% | -9.6% | ||
| Q2 24 | 3.8% | -12.5% | ||
| Q1 24 | 5.4% | -15.6% |
净利率IDTOFIX
| Q4 25 | 6.9% | -1.0% | ||
| Q3 25 | 5.3% | -11.1% | ||
| Q2 25 | 7.2% | -6.9% | ||
| Q1 25 | 6.7% | -27.4% | ||
| Q4 24 | 5.6% | -13.5% | ||
| Q3 24 | 11.9% | -13.9% | ||
| Q2 24 | 1.9% | -16.8% | ||
| Q1 24 | 4.9% | -19.1% |
每股收益（稀释后）IDTOFIX
| Q4 25 | $0.89 | $-0.05 | ||
| Q3 25 | $0.67 | $-0.57 | ||
| Q2 25 | $0.86 | $-0.36 | ||
| Q1 25 | $0.80 | $-1.35 | ||
| Q4 24 | $0.68 | $-0.76 | ||
| Q3 24 | $1.45 | $-0.71 | ||
| Q2 24 | $0.22 | $-0.88 | ||
| Q1 24 | $0.57 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $189.3M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $320.7M | $450.0M |
| 总资产 | $654.9M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IDTOFIX
| Q4 25 | $189.3M | $82.0M | ||
| Q3 25 | $226.5M | $62.9M | ||
| Q2 25 | $199.9M | $65.6M | ||
| Q1 25 | $142.2M | $58.0M | ||
| Q4 24 | $148.0M | $83.2M | ||
| Q3 24 | $164.6M | $30.1M | ||
| Q2 24 | $139.8M | $26.4M | ||
| Q1 24 | $141.1M | $27.0M |
总债务IDTOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益IDTOFIX
| Q4 25 | $320.7M | $450.0M | ||
| Q3 25 | $305.1M | $442.5M | ||
| Q2 25 | $286.2M | $458.3M | ||
| Q1 25 | $271.6M | $458.3M | ||
| Q4 24 | $260.6M | $503.1M | ||
| Q3 24 | $246.2M | $525.9M | ||
| Q2 24 | $214.5M | $546.0M | ||
| Q1 24 | $211.8M | $570.3M |
总资产IDTOFIX
| Q4 25 | $654.9M | $850.6M | ||
| Q3 25 | $626.2M | $832.6M | ||
| Q2 25 | $600.9M | $837.2M | ||
| Q1 25 | $575.7M | $823.1M | ||
| Q4 24 | $554.6M | $893.3M | ||
| Q3 24 | $550.1M | $867.9M | ||
| Q2 24 | $517.3M | $882.0M | ||
| Q1 24 | $521.8M | $906.0M |
负债/权益比IDTOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-16.0M | $16.8M |
| 自由现金流率自由现金流/营收 | -4.9% | 7.6% |
| 资本支出强度资本支出/营收 | 1.8% | 4.9% |
| 现金转化率经营现金流/净利润 | -0.45× | — |
| 过去12个月自由现金流最近4个季度 | $95.4M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流IDTOFIX
| Q4 25 | $-10.1M | $27.7M | ||
| Q3 25 | $31.0M | $12.4M | ||
| Q2 25 | $75.7M | $11.6M | ||
| Q1 25 | $20.2M | $-18.4M | ||
| Q4 24 | $164.0K | $23.7M | ||
| Q3 24 | $25.4M | $11.7M | ||
| Q2 24 | $9.5M | $9.0M | ||
| Q1 24 | $28.4M | $-18.6M |
自由现金流IDTOFIX
| Q4 25 | $-16.0M | $16.8M | ||
| Q3 25 | $25.7M | $2.5M | ||
| Q2 25 | $70.3M | $4.5M | ||
| Q1 25 | $15.3M | $-25.1M | ||
| Q4 24 | $-5.1M | $15.2M | ||
| Q3 24 | $20.1M | $6.3M | ||
| Q2 24 | $4.7M | $-360.0K | ||
| Q1 24 | $23.9M | $-29.1M |
自由现金流率IDTOFIX
| Q4 25 | -4.9% | 7.6% | ||
| Q3 25 | 8.1% | 1.2% | ||
| Q2 25 | 23.3% | 2.2% | ||
| Q1 25 | 5.1% | -13.0% | ||
| Q4 24 | -1.7% | 7.0% | ||
| Q3 24 | 6.5% | 3.2% | ||
| Q2 24 | 1.6% | -0.2% | ||
| Q1 24 | 8.1% | -15.4% |
资本支出强度IDTOFIX
| Q4 25 | 1.8% | 4.9% | ||
| Q3 25 | 1.7% | 4.8% | ||
| Q2 25 | 1.8% | 3.5% | ||
| Q1 25 | 1.6% | 3.5% | ||
| Q4 24 | 1.7% | 4.0% | ||
| Q3 24 | 1.7% | 2.7% | ||
| Q2 24 | 1.6% | 4.7% | ||
| Q1 24 | 1.5% | 5.6% |
现金转化率IDTOFIX
| Q4 25 | -0.45× | — | ||
| Q3 25 | 1.84× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 1.71× | — | ||
| Q1 24 | 1.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDT
| IDT Digital Payments | $104.4M | 32% |
| IDT Global | $60.2M | 19% |
| BOSS Revolution | $45.7M | 14% |
| National Retail Solutions | $39.3M | 12% |
| BOSS Revolution Money Transfer | $36.3M | 11% |
| Net2phone | $23.9M | 7% |
| Other | $8.0M | 2% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
